Role of linoleic acid hydroperoxide preformed by cyclooxygenase-1 or -2 on the regulation of prostaglandin formation from arachidonic acid by the respective enzyme

Journal of Clinical Biochemistry and Nutrition

Volumn 43, Issue 2, 2008, Pages 65-68

  Fujimoto, Yohko ^a   Yonemura, Toshimitsu ^a   Sakuma, Satoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Arachidonic acid; Cyclooxygenase 1; Cyclooxygenase 2; Linoleic acid hydroperoxide; Prostaglandin

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HYDROPEROXIDE; HYDROPEROXY 9,11 OCTADECANOIC ACID; LINOLEIC ACID; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; STEARIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MALE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN FUNCTION; RAM (SHEEP);

EID: 54949135192     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2008047     Document Type: Article

References (23)

1. Simmons, D.L., Botting, R.M., and Hla, T.: Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev., 56, 387-437, 2004.
2. Cryer, B. and Dubois, A.: The advent of highly selective inhibitors of cyclooxygenase - a review. Prostaglandins Other Lipid Mediat., 56, 341-361, 1998.
3. Dubois, R.N., Abramson, S.B., Crofford, L., Gupta, R.A., Simon, L.S., Van De Putte, L.B., and Lipsky, P.E.: Cyclooxygenase in biology and disease. FASEB J., 12, 1063-1073, 1998.
4. Garavito, R.M. and DeWitt, D.L.: The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins. Biochim. Biophys. Acta, 1441, 278-287, 1999.
5. Pace-Asciak, C. and Wolfe, L.S.: Inhibition of prostaglandin synthesis by oleic, linoleic and linolenic acids. Biochim. Biophys. Acta, 152, 784-787, 1968.
6. 2 in human skin: subcellular localization and inhibition by unsaturated fatty acids and anti-inflammatory drugs. J. Lipid Res., 14, 377-384, 1973.
7. Fujimoto, Y., Nakajima, T., Murakami, Y., Takami, K., Nishida, H., Sakuma, S., and Fujita, T.: Effects of fatty acylcoenzyme A esters on prostaglandin synthesis in rabbit kidney medulla microsomes. Prostaglandins Leukot. Essent. Fatty Acids, 47, 265-268, 1992.
8. Ringbom, T., Huss, U., Stenholm, A., Flock, S., Skattebol, L., Perera, P., and Bohlin, L.: COX-2 inhibitory effects of naturally occurring and modified fatty acids. J. Nat. Prod., 64, 745-749, 2001.
9. Funk, C.D. and Powell, W.S.: Release of prostaglandin and monohydroxy and trihydroxy metabolites of linoleic and arachidonic acids by adult and fetal aortae and ductus arteriosus. J. Biol. Chem., 260, 7481-7488, 1985.
10. Daret, D., Blin, P., and Larrue, J.: Synthesis of hydroxy fatty acids from linoleic acid by human blood platelets. Prostaglandins, 38, 203-214, 1989.
11. Fujimoto, Y., Sumiya, T., Tsunomori, M., Nishida, H., Sakuma, S., and Fujita, T.: Effect of 13-hydroperoxy-9,11-octadecadienoic acid (13-HPODE) on arachidonic acid metabolism in rabbit platelets. Int. J. Biochem., 26, 127-131, 1994.
12. Laneuville, O., Breuer, D.K., Xu, N., Huang, Z.H., Gage, D.A., Watson, J.T., Lagarde, M., DeWitt, D.L., and Smith, W.L.: Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. J. Biol. Chem., 270, 19330-19336, 1995.
13. Fujimoto, Y., Nakatani, E., Minamino, H., Takahashi, M., Sakuma, S., and Fujita, T.: Effective use of rabbit gastric antral mucosal slices in prostaglandin synthesis and metabolism studies. Biochim. Biophys. Acta, 1044, 65-69, 1990.
14. Fujimoto, Y., Sakuma, S., Tsunomori, M., Sumiya, T., and Fujita, T.: Sphingomyelin inhibits platelet 12-lipoxygenase activity. Eur. J. Pharmacol., 378, 233-236, 1999.
15. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., and Otomo, S.: NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59, 1994.
16. Fujimoto, Y., Sakuma, S., Inoue, T., Uno, E., and Fujita, T.: The endocrine disruptor nonylphenol preferentially blocks cyclooxygenase-1. Life Sci., 70, 2209-2214, 2002.
17. Hemler, M.E. and Lands, W.E.M.: Evidence for a perxode-initiated free radical mechanism of prostaglandin biosynthesis. J. Biol. Chem., 255, 6253-6261, 1980.
18. Nugteren, D.H. and Hazelhof, E.: Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim. Biophys. Acta, 326, 448-461, 1973.
19. Powell, W.S. and Gravelle, F.: Metabolism of eicosapentaenoic acid by aorta: formation of a novel 13-hydroxylated prostaglandin. Biochim. Biophys. Acta, 835, 201-211, 1985.
20. Chen, W., Pawelek, T.R., and Kulmacz, R.J.: Hydroperoxide dependence and cooperative cyclooxygenase kinetics in prostaglandin H synthase-1 and -2. J. Biol. Chem., 274, 20301-20306, 1999.
21. Liu, W., Gao, D., Oh, S.F., Serhan, C.N., and Kulmacz, R.J.: Divergent cyclooxygenase responses to fatty acid structure and peroxide level in fish and mammalian prostaglandin H synthases. FASEB J., 20, 1097-1108, 2006.
22. 2 and C in rabbit kidney medulla slices. Biochem. J., 218, 69-74, 1984.
23. Cho, B.H.: Lipid composition and cholesterol esterifying activity in microsomal preparations of porcine coronary arteries and heart tissue. Biochem. Med., 29, 64-73, 1983.